ECCO - The European CanCer Organisation promotes European cancer research through the organisation of international multidisciplinary meetings
Medinnova's Idea Prize to research group working on early markers for tumors in the digestive system
Every year Medinnova distributes its Idea prize to the best idea with commercial potential originating from employees belonging to the Norwegian Health Region South-East (Helse Sør-Øst).
This years prize went to four employees from the Department of Cancer Prevention: Guro E. Lind (photo), Ragnhild A. Lothe, Rolf I. Skotheim and Terje Ahlquist.
They have identified new biological markers for colorectal tumours. These markers may contribute to the development of a test for discovering cancer at an early stage.
The "Dr. Ragnar Mørk legacy" prize is distributed annually to a scientist who has achieved excellent results throughout years of outstanding research.
The ceremony took place in the seminar room at the Institute for Cancer Research on Friday 22nd of November. Simonsen gave a lecture summarizing her work.
King Olav V's annual prize for cancer research 2007 was on June 14th awarded to Professor Ragnhild A. Lothe from the Department of Cancer Prevention at the Institute for Cancer Research, Rikshospitalet-Radiumhospitalet. King Harald V presented Professor Lothe with this prestigious prize, which is funded by Norwegian Cancer Society.
Ragnhild A. Lothe has been elected as a member of "The Norwegian Academy of Science and Letters".
The membership was confirmed by the handover of a diploma on the 150 years anniversary of the Society May 2007 with King Harald present.
The membership was confirmed by the handover of a diploma at the meeting for the society in Trondheim on January 22nd.
The objective of the Academy is to promote the sciences, and its members are divided into two Divisions, Letters and Sciences.
The ceremony took place at Thursday 29th of November in the seminar room (F4) at the Institute for Cancer Research .
The purpose of the prize is to promote and encourage cancer research at the Norwegian Radium Hospital.
In addition, Anne-Lise Børresen-Dale has recently been elected member of the board of the Cancer Registry of Norway.
The prestigious prize is distributed by the Norwegian Cancer Society.
The award is personal, and amounts to NOK 200.000.
The ceremony took place at the Institute for Cancer Research on Friday 11th of November.
Harald Stenmark new member of the Norwegian Academy of Science and Letters.
Stenmark has been characterizing how growth factor signalling is modulated by intracellular trafficking. He is especially interested in the connection between this cellular pathway and carcinogenesis. Read more about his science on www.radium.no/stenmark.
In order to become a member of this exclusive academy, one has to nominated by other members and elected through a votation.
The "Dr. Ragnar Mørk legacy" prize is distributed annually to a scientist who has achieved excellent results throughout years of outstanding research. This is the fourth time this mark of honor is distributed. The purpose of the prize is to promote and encourage cancer research at the Norwegian Radium Hospital.
Her proposal "Identification of genotypes influencing the global tumour expression profile leading to elevated breast cancer risk, tumour aggressiveness and therapy resistance" convinced the jury members of the Swiss-Bridge Award.
The project will be supported with CHF 250.000,- (NOK 1.325 mill.)
The ceremony took place in Zurich on the 13th of October 2004.
On the occasion of EACR-18 the award will be presented to Therese Sørlie.
Read the article on kreft.no (in Norwegian)
Read the article here (in Norwegian)
Read the article from Dagens Medisin (in Norwegian)
Sandvig selected member in Academia Europea
Nordic million prize to Anne Lise Børresen-Dale
EMBO membership to Harald Stenmark
EMBO runs a number of courses, seminars and grant programmes, and evaluate research quality. EMBO runs to journals.
EMBO's home page